AlanSheldonLichtbrounMD
Rheumatology • East Brunswick, NJAssistant Clinical Professor of Medicine, UMDNJ-RW Johnson Medical School
Dr. Lichtbroun is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
63 Brunswick Woods Dr
East Brunswick, NJ 08816Phone+1 732-613-1900Fax+1 732-613-0029
Education & Training
Icahn School of Medicine at Mount SinaiFellowship, Rheumatology, 1981 - 1982
Zucker School of Medicine at Hofstra/NorthwellResidency, Internal Medicine, 1977 - 1980
State University of New York Downstate Medical Center College of MedicineClass of 1977
Certifications & Licensure
FL State Medical License 1984 - Present
NJ State Medical License 1982 - 2025
NY State Medical License 1978 - 1997
American Board of Internal Medicine Internal Medicine- American Board of Internal Medicine Rheumatology
Awards, Honors, & Recognition
- Inside Jersey Magazine Top Doctors Castle Connolly, 2010-2014
- Top Doctors: New York Metro Area Castle Connolly, 2002-2014
- Meaningful Use Stage 1 Certification Centers for Medicare & Medicaid Services, 2011
- Join now to see all
Publications & Presentations
PubMed
- 23 citationsNovel Sjögren's autoantibodies found in fibromyalgia patients with sicca and/or xerostomiaEliana Applbaum, Alan Lichtbroun
Autoimmunity Reviews. 2019-02-01 - 1 citationsPositive Findings on an Early Autoantibody Panel in Sjögren's Syndrome Often Predate Positive Findings on Classic Tests: Comment on the Article by Theander et al.Alan S. Lichtbroun
Arthritis & Rheumatology. 2016-08-01 - 35 citationsA Pilot Study of External Qigong Therapy for Patients with FibromyalgiaKevin Chen, Afton L. Hassett, Faxiang Hou, Joy Staller, Alan S. Lichtbroun
Journal of Alternative and Complementary Medicine. 2006-11-16
Press Mentions
Kane in Your Corner: Did FDA Wait Too Long to Warn About Popular Antibiotic Levaquin?May 18th, 2016
Professional Memberships
- Fellow
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
